Varianten der Geschlechtsentwicklung - ein klinisches und rechtliches Update

Varianten der Geschlechtsentwicklung umfassen eine Vielzahl von klinischen Entitäten, die sehr variable klinische Bilder aufzeigen können. Die einzelnen Varianten gehören zu den seltenen Erkrankungen. Dennoch ist es für klinisch tätige Pädiater*innen wichtig zu wissen, was Varianten der Geschlechtsentwicklung sind, wie sie klassifiziert und diagnostiziert werden und worauf man im Umgang mit Betroffenen und ihren Familien achten sollte.

Schlüsselwörter

Geschlechtsdifferenzierung - Varianten - DSD - Chromosomenanomalien - rechtlicher Rahmen

Keywords

gender differentiation - variants - DSD - chromosomal abnormalities - legal basis

• Literatur

• 1 Lee PA, Nordenström A, Houk CP. et al. Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care. Horm Res Paediatr 2006; 85: 158-180
• 2 Nielsen J, Wohler M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991; 87: 81-83
• 3 Lindhardt Johansen M, Hagen CP, Rajpert-De Meyts E. et al. 45,X/46,XY mosaicism: phenotypic characteristics, growth, and reproductive function--a retrospective longitudinal study. J Clin Endocrinol Metab 2012; 97: E1540-E1549
• 4 Hughes IA. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab 2008; 22: 119-134
• 5 Hughes IA, Houk C, Ahmed SF. et al. Consensus statement on management of intersex disorders. J Pediatr Urol 2006; 2: 148-162
• 6 Werner R, Merz H, Birnbaum W. et al. 46,XY Gonadal Dysgenesis due to a Homozygous Mutation in Desert Hedgehog (DHH) Identified by Exome Sequencing. J Clin Endocrinol Metab 2015; 100: E1022-E1029
• 7 Werner R, Monig I, Lunstedt R. et al. New NR5A1 mutations and phenotypic variations of gonadal dysgenesis. PLoS One 2017; 12: e0176720
• 8 Reardon S. The spectrum of sex development: Eric Vilain and the intersex controversy. Nature 2016; 533: 160-163
• 9 Andrade JGR, Fabbri-Scallet H, Dos Santos AP. et al. Clinical Findings and Follow-Up of 46,XY and 45,X/46,XY Testicular Dysgenesis. Sex Dev 2019; 13: 171-177
• 10 Savage MO, Lowe DG. Gonadal neoplasia and abnormal sexual differentiation. Clin Endocrinol (Oxf) 1990; 32: 519-533
• 11 Kalra R, Cameron M, Stern C. Female fertility preservation in DSD. Best Pract Res Clin Endocrinol Metab 2019; 33: 101289
• 12 Hiort O, Marshall L, Birnbaum W. et al. Pubertal Development in 17Beta-Hydroxysteroid Dehydrogenase Type 3 Deficiency. Horm Res Paediatr 2017; 87: 354-358
• 13 Imperato-McGinley J. 5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature. Adv Exp Med Biol 2002; 511: 121-131
• 14 Imperato-McGinley J, Peterson RE, Gautier T. et al. Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 alpha-reductase deficiency. J Clin Endocrinol Metab 1982; 54: 931-941
• 15 Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol 2002; 198: 51-59
• 16 Audi L, Ahmed SF, Krone N. et al. Genetics in Endocrinology: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’. Eur J Endocrinol 2018; 179: R197-R206
• 17 Sinnecker GH, Hiort O, Dibbelt L. et al. Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. Am J Med Genet 1996; 63: 223-230
• 18 Quigley CA, De Bellis A, Marschke KB. et al. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16: 271-321
• 19 Gottlieb B, Beitel LK, Wu J. et al. Nuclear receptors and disease: androgen receptor. Essays Biochem 2004; 40: 121-136
• 20 Han TS, Goswami D, Trikudanathan S. et al. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur J Endocrinol 2008; 159: 179-185
• 21 Doehnert U, Bertelloni S, Werner R. et al. Characteristic features of reproductive hormone profiles in late adolescent and adult females with complete androgen insensitivity syndrome. Sex Dev 2015; 9: 69-74
• 22 Johannsen TH, Andersson AM, Ahmed SF. et al. Peptide hormone analysis in diagnosis and treatment of Differences of Sex Development: joint position paper of EU COST Action ‘DSDnet’ and European Reference Network on Rare Endocrine Conditions. Eur J Endocrinol 2020; 182: P1-P15
• 23 Looijenga LH, Hersmus R, Oosterhuis JW. et al. Tumor risk in disorders of sex development (DSD). Best Pract Res Clin Endocrinol Metab 2007; 21: 480-495
• 24 Looijenga LHJ, Kao CS, Idrees MT. Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology. Int J Mol Sci 2019; 20: 5017
• 25 Doehnert U, Wunsch L, Hiort O. Gonadectomy in Complete Androgen Insensitivity Syndrome: Why and When?. Sex Dev 2017; 11: 171-174
• 26 Birnbaum W, Marshall L, Werner R. et al. Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial. Lancet Diabetes Endocrinol 2018; 6: 771-780
• 27 T’Sjoen G, De Cuypere G, Monstrey S. et al. Male gender identity in complete androgen insensitivity syndrome. Arch Sex Behav 2011; 40: 635-638
• 28 Hornig NC, Holterhus PM. Molecular basis of androgen insensitivity syndromes. Mol Cell Endocrinol 2021; 523: 111146
• 29 Imbeaud S, Belville C, Messika-Zeitoun L. et al. A 27 base-pair deletion of the anti-mullerian type II receptor gene is the most common cause of the persistent mullerian duct syndrome. Hum Mol Genet 1996; 5: 1269-1277
• 30 Narita O, Manba S, Nakanishi T. et al. Pregnancy and childbirth in a true hermaphrodite. Obstet Gynecol 1975; 45: 593-595
• 31 McElreavey K, Fellous M. Sex-determining genes. Trends Endocrinol Metab 1997; 8: 342-346
• 32 Prader A. [For the development of the chorda dorsalis of humans]. Bull Histol Appl Physiol Pathol Tech Microsc 1945; 22: 138
• 33 van der Straaten S, Springer A, Zecic A. et al. The External Genitalia Score (EGS): A European Multicenter Validation Study. J Clin Endocrinol Metab 2020; 105: dgz142
• 34 Ahmed SF, Rodie M. Investigation and initial management of ambiguous genitalia. Best Pract Res Clin Endocrinol Metab 2010; 24: 197-218
• 35 Bundesärztekammer. Stellungnahme zu „Versorgung von Kindern, Jugendlichen und Erwachsenen mit Varianten/Störungen der Geschlechtsentwicklung (Disorders of Sex Development, DSD)“. Dtsch Arztebl Ausg A 2015;
• 36 Bundeszentrale für politische Bildung. Koalitionsvertrag zwischen CDU, CSU und SPD. Ein neuer Aufbruch für Europa. Eine neue Dynamik für Deutschland. Ein neuer Zusammenhalt für unser Land. Berlin: 2018. S. 21, Z. 797 Accessed May 23, 2023 at: https://www.bpb.de/system/files/dokument_pdf/Koalitionsvertrag_2018.pdf
• 37 Presse- und Informationsamt der Bundesregierung. Koalitionsvertrag zwischen SPD, Bündnis 90/Die Grünen und FDP. Mehr Fortschritt Wagen. Bündnis für Freiheit, Gerechtigkeit und Nachhaltigkeit. Berlin: 2021: 119 Accessed May 23, 2023 at: https://www.bundesregierung.de/breg-de/aktuelles/koalitionsvertrag-2021–1990800